{
    "body_text": [
        {
            "endOffset": 20777,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0045",
            "sentence": "The pathophysiology of cesarean scar pregnancies is similar to an intrauterine pregnancy with morbidly adherent placentation [32].",
            "startOffset": 20647,
            "title": "Cesarean scar pregnancy"
        },
        {
            "endOffset": 44291,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "Level 2: Criteria as specified in the Antenatal Bleeding case definitions.",
            "startOffset": 44217,
            "title": "Data analysis"
        },
        {
            "endOffset": 47183,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "The distribution of data (as numerator and denominator data) could be analyzed in predefined increments (e.g. measured values, times), where applicable.",
            "startOffset": 47031,
            "title": "Data analysis"
        },
        {
            "endOffset": 15859,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The search also resulted in the identification of 1 reference containing information regarding vaccination administration and antenatal bleeding (as defined by the listed PubMed search terms above).",
            "startOffset": 15661,
            "title": "Methods for the development of the case definition, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 17663,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0030",
            "sentence": "Invasive placentation occurs as a result of the absence of the decidua basalis and incomplete development of or injury to Nitabuch\u2019s layer [1,5,8].",
            "startOffset": 17516,
            "title": "Morbidly adherent placentation"
        },
        {
            "endOffset": 34204,
            "parents": [],
            "secId": "s0160",
            "sentence": "It was the consensus of the Brighton Collaboration Antenatal Bleeding Working Group to recommend the following guidelines to enable meaningful and standardized collection, analysis, and presentation of information about antenatal bleeding.",
            "startOffset": 33965,
            "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
        },
        {
            "endOffset": 43132,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "Events that meet the case definition should be classified according to the levels of diagnostic certainty as specified in the case definition.",
            "startOffset": 42990,
            "title": "Data analysis"
        },
        {
            "endOffset": 15420,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "To guide decision-making for case definitions, a literature search was performed in PubMed, including the following terms: pregnancy, antenatal bleeding, antepartum bleeding, antepartum hemorrhage, placenta previa, vasa previa, abruptio placenta, placenta accreta, morbidly adherent placenta, abdominal pregnancy, cesarean scar pregnancy, uterine rupture, abdominal pregnancy, intra-abdominal pregnancy, and vaccination.",
            "startOffset": 15000,
            "title": "Methods for the development of the case definition, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 29914,
            "parents": [
                {
                    "id": "s0115",
                    "title": "Case definition of antenatal bleeding3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0120",
            "sentence": "For each definition, the diagnostic levels reflect diagnostic certainty and must not be misunderstood as reflecting different grades of clinical severity.",
            "startOffset": 29760,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 34751,
            "parents": [],
            "secId": "s0160",
            "sentence": "Also, as explained in more detail in the overview paper in this volume, these are intended as guidelines and are not to be considered a mandatory requirement for data collection, analysis, or presentation.",
            "startOffset": 34546,
            "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
        },
        {
            "endOffset": 19393,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0035",
            "sentence": "Other risk factors include first trimester bleeding, hypertension, thrombophilia, illicit drug use (especially cocaine), smoking, trauma, in vitro fertilization, and premature rupture of membranes [23\u201326].",
            "startOffset": 19188,
            "title": "Placental abruption"
        },
        {
            "endOffset": 30021,
            "parents": [
                {
                    "id": "s0115",
                    "title": "Case definition of antenatal bleeding3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0120",
            "sentence": "Moreover, defining levels of clinical severity of antenatal bleeding is beyond the scope of this document.",
            "startOffset": 29915,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 19187,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0035",
            "sentence": "Abruption affects about 1% of pregnancies, but is associated with a recurrence risk of about 10\u201315% for one prior abruption, 20\u201330% after two, and \u226530% after three or more abruptions [21,22].",
            "startOffset": 18996,
            "title": "Placental abruption"
        },
        {
            "endOffset": 28340,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0105",
            "sentence": "Case definitions and guidelines are not intended to guide or establish criteria for management of ill infants, children, or adults.",
            "startOffset": 28209,
            "title": "Guidelines for data collection, analysis and presentation"
        },
        {
            "endOffset": 38609,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                }
            ],
            "secId": "s0190",
            "sentence": "The anatomical sites (including left or right side) of all immunizations (e.g. vaccine A in proximal left lateral thigh, vaccine B in left deltoid).",
            "startOffset": 38461,
            "title": "Details of the immunization"
        },
        {
            "endOffset": 23966,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                }
            ],
            "secId": "s0065",
            "sentence": "The grading of definition levels is about diagnostic certainty, not clinical severity of an event.",
            "startOffset": 23868,
            "title": "Formulating case definitions that reflect diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 16535,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0025",
            "sentence": "This is in contrast with low-lying placenta, in which the placenta lies within 2 cm of the internal cervical os but does not extend across it.",
            "startOffset": 16393,
            "title": "Placenta previa"
        },
        {
            "endOffset": 49533,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0210",
            "sentence": "The source of the denominator data should be reported and calculations of estimates be described (e.g. manufacturer data like total doses distributed, reporting through Ministry of Health, coverage/population based data, etc.).",
            "startOffset": 49306,
            "title": "Data presentation"
        },
        {
            "endOffset": 11693,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The goal of this Working Group was two-fold:",
            "startOffset": 11649,
            "title": "Need for developing case definitions, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 26006,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                }
            ],
            "secId": "s0090",
            "sentence": "Prenatal ultrasound uses sound waves passing through an acoustic window to visualize deeper tissue and structures, including a fetus.",
            "startOffset": 25873,
            "title": "Safety of imaging in pregnancy"
        },
        {
            "endOffset": 22657,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0055",
            "sentence": "Risk factors for uterine rupture in an unscarred uterus include a contracted pelvis, prolonged dystotic labor, multiparity, morbidly adherent placentation, malpresentation, use of strong uterotonic drugs perhaps with cephalopelvic disproportion, operative vaginal deliveries at high station, and congenital weakness of the myometrium [35].",
            "startOffset": 22318,
            "title": "Uterine rupture"
        },
        {
            "endOffset": 29253,
            "parents": [
                {
                    "id": "s0115",
                    "title": "Case definition of antenatal bleeding3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0120",
            "sentence": "For both levels of diagnostic certainty for each etiology of antenatal bleeding:",
            "startOffset": 29173,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 18497,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0035",
            "sentence": "Traditionally conceptualized as primarily an \u201cacute\u201d event often resulting from physical trauma to the abdomen, contemporary data suggest that placental abruption is often chronic [13\u201317].",
            "startOffset": 18309,
            "title": "Placental abruption"
        },
        {
            "endOffset": 23127,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0055",
            "sentence": "Additional risk factors include the number of prior cesarean deliveries, interdelivery interval less than 18 months, one-layer uterine closure, and open fetal surgery [40\u201342].",
            "startOffset": 22952,
            "title": "Uterine rupture"
        },
        {
            "endOffset": 45832,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "We caution that all episodes of bleeding that occur temporally after vaccination may not be causally linked.",
            "startOffset": 45724,
            "title": "Data analysis"
        },
        {
            "endOffset": 22951,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0055",
            "sentence": "The incidence of this event ranges from approximately 1 in 200 up to 1 in 10, depending on the type of hysterotomy and the use of labor augmentation [38,39].",
            "startOffset": 22794,
            "title": "Uterine rupture"
        },
        {
            "endOffset": 48506,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0210",
            "sentence": "Additionally, it is recommended to refer to existing general guidelines for the presentation and publication of randomized controlled trials, systematic reviews, and meta-analyzes of observational studies in epidemiology (e.g. statements of Consolidated Standards of Reporting Trials (CONSORT), of Improving the quality of reports of meta-analyzes of randomized controlled trials (QUORUM), and of meta-analysis Of Observational Studies in Epidemiology (MOOSE), respectively).",
            "startOffset": 48031,
            "title": "Data presentation"
        },
        {
            "endOffset": 50354,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0210",
            "sentence": "The type of surveillance (e.g. passive or active surveillance).",
            "startOffset": 50291,
            "title": "Data presentation"
        },
        {
            "endOffset": 49776,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0210",
            "sentence": "If the distribution of data is skewed, median and range are usually the more appropriate statistical descriptors than a mean.",
            "startOffset": 49651,
            "title": "Data presentation"
        },
        {
            "endOffset": 26955,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                }
            ],
            "secId": "s0095",
            "sentence": "As noted in the preamble of this document, both immunizations and antenatal bleeding are common events in pregnancy.",
            "startOffset": 26839,
            "title": "Timing of adverse event with relation to timing of immunization"
        },
        {
            "endOffset": 49142,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0210",
            "sentence": "Data should be presented with numerator and denominator (n/N) (and not only in percentages), if available.",
            "startOffset": 49036,
            "title": "Data presentation"
        },
        {
            "endOffset": 11649,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In cases of severe antepartum hemorrhage, complications include preterm delivery, cesarean delivery, blood transfusion, coagulopathy, hemodynamic instability, multi-organ failure, salpingectomy/oophorectomy, peripartum hysterectomy, and in some cases, either perinatal or maternal death.",
            "startOffset": 11362,
            "title": "Need for developing case definitions, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 11972,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "to define each source of antenatal bleeding for the purposes of future case ascertainment.",
            "startOffset": 11882,
            "title": "Need for developing case definitions, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 27940,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                }
            ],
            "secId": "s0100",
            "sentence": "The Brighton Working Group on Pathways of Preterm Birth describes the pathophysiology of preterm labor in detail [3].",
            "startOffset": 27823,
            "title": "Differentiation from other associated disorders"
        },
        {
            "endOffset": 35740,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0165",
            "sentence": "Guidelines numbers below have been developed to address data elements for the collection of adverse event information as specified in general drug safety guidelines by the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use [49], and the form for reporting of drug adverse events by the Council for International Organizations of Medical Sciences [50].",
            "startOffset": 35322,
            "title": "Data collection"
        },
        {
            "endOffset": 18191,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0030",
            "sentence": "Other common risk factors include advanced maternal age, advanced parity, cesarean scar pregnancy, and in vitro fertilization [5,7,10\u201312].",
            "startOffset": 18053,
            "title": "Morbidly adherent placentation"
        },
        {
            "endOffset": 14730,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Following the process described in the overview paper [4] as well as on the Brighton Collaboration Website http://www.brightoncollaboration.org/internet/en/index/process.html, the Brighton Collaboration Antenatal Bleeding Working Group was formed in 2016 and includes members with a diverse background in clinical experience, location of practice, and scientific expertise in sources of antenatal bleeding.",
            "startOffset": 14324,
            "title": "Methods for the development of the case definition, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 38267,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                }
            ],
            "secId": "s0190",
            "sentence": "Date and time of immunization(s).",
            "startOffset": 38234,
            "title": "Details of the immunization"
        },
        {
            "endOffset": 16024,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "We first begin with a brief description of each etiology, the underlying pathophysiology, incidence, and risk factors.",
            "startOffset": 15906,
            "title": "Description of sources of antenatal bleeding"
        },
        {
            "endOffset": 50023,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0210",
            "sentence": "It is essential to specify:",
            "startOffset": 49996,
            "title": "Data presentation"
        },
        {
            "endOffset": 12339,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In the case of antenatal bleeding, our Working Group felt strongly that there is no biologic plausibility or mechanistic explanation linking immunizations to antenatal bleeding.",
            "startOffset": 12162,
            "title": "Need for developing case definitions, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 18551,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0035",
            "sentence": "Nevertheless, acute placental abruptions still occur.",
            "startOffset": 18498,
            "title": "Placental abruption"
        },
        {
            "endOffset": 21168,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0045",
            "sentence": "As the recognition of cesarean scar pregnancies is relatively recent, risk factors are not yet clear; however, as with morbidly adherent placentation, the incidence appears to correlate with the number of prior cesarean deliveries [32].",
            "startOffset": 20932,
            "title": "Cesarean scar pregnancy"
        },
        {
            "endOffset": 13214,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In this document, we focus on placenta previa, morbidly adherent placentation, vasa previa, placental abruption, cesarean scar pregnancy, intra-abdominal pregnancy, and uterine rupture as important sources of antenatal bleeding.",
            "startOffset": 12986,
            "title": "Need for developing case definitions, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 50629,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0210",
            "sentence": "The instrument of data collection (e.g. - questionnaire, diary card, report form).",
            "startOffset": 50547,
            "title": "Data presentation"
        },
        {
            "endOffset": 27098,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                }
            ],
            "secId": "s0095",
            "sentence": "We feel strongly there is no current evidence or biological plausibility to suggest a causal link between immunization and antenatal bleeding.",
            "startOffset": 26956,
            "title": "Timing of adverse event with relation to timing of immunization"
        },
        {
            "endOffset": 44137,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "Event meets case definition",
            "startOffset": 44110,
            "title": "Data analysis"
        },
        {
            "endOffset": 48630,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0210",
            "sentence": "All reported events of antenatal bleeding should be presented according to the categories listed in guideline 31 and 32.",
            "startOffset": 48510,
            "title": "Data presentation"
        },
        {
            "endOffset": 16991,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0025",
            "sentence": "These risk factors suggest that the pathogenesis may be driven by endometrial damage or suboptimal endometrial perfusion in other areas of the uterus.",
            "startOffset": 16841,
            "title": "Placenta previa"
        },
        {
            "endOffset": 36229,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                }
            ],
            "secId": "s0170",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 36123,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 37151,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                },
                {
                    "id": "s0175",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0180",
            "sentence": "For infants: Gestational age and birth weight.",
            "startOffset": 37105,
            "title": "Demographics"
        },
        {
            "endOffset": 48030,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0210",
            "sentence": "These guidelines represent a desirable standard for the presentation and publication of data on antenatal bleeding that occurs in a pregnancy in which immunizations are also administered to allow for comparability of data, and are recommended as an addition to data presented for the specific study question and setting.",
            "startOffset": 47710,
            "title": "Data presentation"
        },
        {
            "endOffset": 13572,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Nonetheless, we included these causes as they are more likely to result in late presentation with a high risk of heavy maternal bleeding in settings in which ultrasound diagnosis of pregnancy is limited or unavailable.",
            "startOffset": 13354,
            "title": "Need for developing case definitions, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 36088,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0165",
            "sentence": "Additional guidelines have been developed as direction for the collection of additional information to allow for a more comprehensive understanding of antenatal bleeding [4,43].",
            "startOffset": 35911,
            "title": "Data collection"
        },
        {
            "endOffset": 21623,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0050",
            "sentence": "Pregnancies may be asymptomatic, or may present with life-threatening intra-abdominal hemorrhage.",
            "startOffset": 21526,
            "title": "Intra-abdominal pregnancy"
        },
        {
            "endOffset": 24215,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                }
            ],
            "secId": "s0065",
            "sentence": "Thus, a clinically very severe event may appropriately be classified as Level 2 or 3 rather than Level 1 if it could reasonably be of an alternative etiology \u2013 either another cause of antenatal bleeding, or unrelated to antenatal bleeding entirely.",
            "startOffset": 23967,
            "title": "Formulating case definitions that reflect diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 51369,
            "parents": [],
            "secId": "s0215",
            "sentence": "They do not necessarily represent the official positions of each participant\u2019s organization.",
            "startOffset": 51277,
            "title": "Disclaimer"
        },
        {
            "endOffset": 12986,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Standardized definitions across trials, surveillance systems, or clinical settings will facilitate case ascertainment and analysis of potential risk factors for antenatal bleeding.",
            "startOffset": 12806,
            "title": "Need for developing case definitions, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 29584,
            "parents": [
                {
                    "id": "s0115",
                    "title": "Case definition of antenatal bleeding3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0120",
            "sentence": "Bleeding is either documented vaginally or suspected to be occurring intrauterine, intraperitoneally, or (rarely) retroperitoneally, based on clinical signs and symptoms.",
            "startOffset": 29414,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 50503,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0210",
            "sentence": "The search strategy in surveillance databases.",
            "startOffset": 50457,
            "title": "Data presentation"
        },
        {
            "endOffset": 17887,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0030",
            "sentence": "The most significant risk factor is placenta previa in the context of one or more prior cesarean deliveries, or other uterine surgery.",
            "startOffset": 17753,
            "title": "Morbidly adherent placentation"
        },
        {
            "endOffset": 25805,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                },
                {
                    "id": "s0070",
                    "title": "Rationale for individual criteria or decision made related to the case definitions"
                }
            ],
            "secId": "s0085",
            "sentence": "MRI findings may be used in some circumstances when this modality is available.",
            "startOffset": 25726,
            "title": "Radiology findings"
        },
        {
            "endOffset": 44110,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "Event classification in 5 categories11",
            "startOffset": 43240,
            "title": "Data analysis"
        },
        {
            "endOffset": 49305,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0210",
            "sentence": "Although immunization safety surveillance systems denominator data are usually not readily available, attempts should be made to identify approximate denominators.",
            "startOffset": 49142,
            "title": "Data presentation"
        },
        {
            "endOffset": 45177,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "The interval between immunization and reported antenatal bleeding (separated out by etiology) could be defined as the date/time of immunization to the date/time of onset4 of the first symptoms and/or signs consistent with the definition.",
            "startOffset": 44940,
            "title": "Data analysis"
        },
        {
            "endOffset": 11066,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Bleeding in the second and third trimesters of pregnancy affects 6% of all pregnancies, and has distinct etiologies from first-trimester bleeding [1].",
            "startOffset": 10916,
            "title": "Need for developing case definitions, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 49995,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0210",
            "sentence": "Any publication of data on antenatal bleeding should include a detailed description of the methods used for data collection and analysis as possible.",
            "startOffset": 49846,
            "title": "Data presentation"
        },
        {
            "endOffset": 15543,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Major obstetric textbooks and published guidelines from major obstetric societies throughout the world were also surveyed.",
            "startOffset": 15421,
            "title": "Methods for the development of the case definition, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 38230,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                }
            ],
            "secId": "s0190",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 38124,
            "title": "Details of the immunization"
        },
        {
            "endOffset": 25033,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                },
                {
                    "id": "s0070",
                    "title": "Rationale for individual criteria or decision made related to the case definitions"
                }
            ],
            "secId": "s0075",
            "sentence": "Histological findings identify many but not all cases of placental abruption.",
            "startOffset": 24956,
            "title": "Pathology findings"
        },
        {
            "endOffset": 43240,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "Events that do not meet the case definition should be classified in the additional categories for analysis.",
            "startOffset": 43133,
            "title": "Data analysis"
        },
        {
            "endOffset": 45336,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "If few cases are reported, the concrete time course could be analyzed for each; for a large number of cases, data can be analyzed in the following increments:",
            "startOffset": 45178,
            "title": "Data analysis"
        },
        {
            "endOffset": 23448,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                }
            ],
            "secId": "s0065",
            "sentence": "The number of signs, symptoms, and diagnostic tests that will be documented for each case may vary considerably.",
            "startOffset": 23336,
            "title": "Formulating case definitions that reflect diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 38092,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                },
                {
                    "id": "s0175",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0185",
            "sentence": "Immunization history (i.e. previous immunizations and any adverse event following immunization (AEFI)), in particular occurrence of antenatal bleeding after a previous immunization.",
            "startOffset": 37911,
            "title": "Clinical and immunization history"
        },
        {
            "endOffset": 11361,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The etiologies of antenatal bleeding, also referred to as antepartum hemorrhage, are heterogeneous.",
            "startOffset": 11262,
            "title": "Need for developing case definitions, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 20138,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0040",
            "sentence": "Type II vasa previa occurs with the development of a succenturiate placental lobe and main placental lobe, connected by fetal vessels that freely course within the membranes.",
            "startOffset": 19964,
            "title": "Vasa previa"
        },
        {
            "endOffset": 44360,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "Additional categories for analysis",
            "startOffset": 44326,
            "title": "Data analysis"
        },
        {
            "endOffset": 19605,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0035",
            "sentence": "This is in contrast to a preterm birth rate of 12% among unaffected pregnancies [26\u201329].",
            "startOffset": 19517,
            "title": "Placental abruption"
        },
        {
            "endOffset": 49647,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0210",
            "sentence": "The incidence of cases in the study population should be presented and clearly identified as such in the text.",
            "startOffset": 49537,
            "title": "Data presentation"
        },
        {
            "endOffset": 20202,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0040",
            "sentence": "Vasa previa is rare, with an incidence of 1 in 2500 deliveries.",
            "startOffset": 20139,
            "title": "Vasa previa"
        },
        {
            "endOffset": 22793,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0055",
            "sentence": "In high-resource settings, uterine rupture most commonly occurs in the context of a prior hysterotomy scar or transfundal surgery [37].",
            "startOffset": 22658,
            "title": "Uterine rupture"
        },
        {
            "endOffset": 28208,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0105",
            "sentence": "As mentioned in the overview paper, the case definition is accompanied by guidelines that are structured according to the steps of conducting a clinical trial, i.e. data collection, analysis and presentation.",
            "startOffset": 28000,
            "title": "Guidelines for data collection, analysis and presentation"
        },
        {
            "endOffset": 16840,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0025",
            "sentence": "Risk factors include smoking, advanced maternal age, multiparity, in vitro fertilization, multiple gestation, Asian race, prior endometrial damage, prior pregnancy termination or spontaneous abortion, prior cesarean delivery, and prior placenta previa [1,5,6].",
            "startOffset": 16580,
            "title": "Placenta previa"
        },
        {
            "endOffset": 18052,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0030",
            "sentence": "With one prior cesarean delivery and a placenta previa, the risk is 11%; with 3 or more cesarean deliveries and a placenta previa, the risk is greater than 60% [9].",
            "startOffset": 17888,
            "title": "Morbidly adherent placentation"
        },
        {
            "endOffset": 24955,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                },
                {
                    "id": "s0070",
                    "title": "Rationale for individual criteria or decision made related to the case definitions"
                }
            ],
            "secId": "s0075",
            "sentence": "Pathologic findings for cesarean scar pregnancy managed by hysterectomy with the gestational sac in-situ is also the gold standard for diagnosis; however, a hysterectomy is not always performed, and histologic confirmation may not be possible.",
            "startOffset": 24712,
            "title": "Pathology findings"
        },
        {
            "endOffset": 28391,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0105",
            "sentence": "Both were developed to improve data comparability.",
            "startOffset": 28341,
            "title": "Guidelines for data collection, analysis and presentation"
        },
        {
            "endOffset": 34285,
            "parents": [],
            "secId": "s0160",
            "sentence": "However, implementation of all guidelines might not be possible in all settings.",
            "startOffset": 34205,
            "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
        },
        {
            "endOffset": 46622,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "The duration of a possible antenatal bleeding event could be analyzed as the interval between the date/time of onset3 of the first symptoms and/or signs consistent with the definition and the end of episode7 and/or final outcome.8",
            "startOffset": 46392,
            "title": "Data analysis"
        },
        {
            "endOffset": 12161,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The charge to the Brighton Collaboration Working Groups to define various adverse obstetric and pediatric events includes an aim to more easily identify immunization-related adverse events.",
            "startOffset": 11972,
            "title": "Need for developing case definitions, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 22317,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0055",
            "sentence": "The incidence of rupture of the unscarred uterus is approximately 1 in 20,000 deliveries in high-resource settings, but can be as high as 1 in 100 deliveries in low-resource settings, where the majority of this type of rupture occurs [35\u201337].",
            "startOffset": 22075,
            "title": "Uterine rupture"
        },
        {
            "endOffset": 46155,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "For example, pre-existing conditions in pregnancy (i.e., history of abdominal trauma, abnormal placentation, abnormal pregnancy implantation) may predispose a patient to an event of antenatal bleeding, with the administration of a vaccination temporally along the pathophysiologic process to bleeding without any relation.",
            "startOffset": 45833,
            "title": "Data analysis"
        },
        {
            "endOffset": 29173,
            "parents": [
                {
                    "id": "s0115",
                    "title": "Case definition of antenatal bleeding3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0120",
            "sentence": "Pathologic etiologies attributable to the pregnant state include placenta previa, morbidly adherent placenta, vasa previa, placental abruption, cesarean scar pregnancy, intra-abdominal pregnancy, and uterine rupture.",
            "startOffset": 28957,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 25373,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                },
                {
                    "id": "s0070",
                    "title": "Rationale for individual criteria or decision made related to the case definitions"
                }
            ],
            "secId": "s0080",
            "sentence": "No specific laboratory findings were included in case definitions of antenatal bleeding, as none of these clinical entities are associated with specific or identifiable laboratory parameters.",
            "startOffset": 25182,
            "title": "Laboratory findings"
        },
        {
            "endOffset": 25725,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                },
                {
                    "id": "s0070",
                    "title": "Rationale for individual criteria or decision made related to the case definitions"
                }
            ],
            "secId": "s0085",
            "sentence": "Ultrasound findings in a pregnancy complicated by antenatal bleeding are highly important in identifying and differentiating several conditions and thus are included in many case definitions.",
            "startOffset": 25534,
            "title": "Radiology findings"
        },
        {
            "endOffset": 16273,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Incidence data not derived from these areas is specified in the following paragraphs.",
            "startOffset": 16188,
            "title": "Description of sources of antenatal bleeding"
        },
        {
            "endOffset": 18842,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0035",
            "sentence": "Pathophysiologic mechanisms involved in abruption include uteroplacental underperfusion, ischemia, placental infarctions, and chronic hypoxia [18\u201320].",
            "startOffset": 18692,
            "title": "Placental abruption"
        },
        {
            "endOffset": 46388,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "Please refer to the Brighton Collaboration document on establishing gestational age.",
            "startOffset": 46304,
            "title": "Data analysis"
        },
        {
            "endOffset": 13643,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Another common source of bleeding is labor, whether at term or preterm.",
            "startOffset": 13572,
            "title": "Need for developing case definitions, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 12536,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Moreover, as immunizations and antenatal bleeding are common occurrences in the course of any individual pregnancy, it is quite likely that these events will co-occur without suggesting causation.",
            "startOffset": 12340,
            "title": "Need for developing case definitions, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 13766,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Although preterm labor is pathologic and addressed in another document [3], bleeding in the context of labor alone is not.",
            "startOffset": 13644,
            "title": "Need for developing case definitions, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 17282,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0025",
            "sentence": "The incidence of placenta previa at term is approximately 1 in 200 pregnancies; the incidence is higher earlier in gestation, but many placenta previas resolve as the lower uterine segment develops and the placenta preferentially expands towards more vascularized areas of the uterus [1,5].",
            "startOffset": 16992,
            "title": "Placenta previa"
        },
        {
            "endOffset": 38457,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                }
            ],
            "secId": "s0190",
            "sentence": "Description of vaccine(s) (name of vaccine, manufacturer, lot number, dose (e.g. 0.25 mL, 0.5 mL, etc.) and number of dose if part of a series of immunizations against the same disease).",
            "startOffset": 38271,
            "title": "Details of the immunization"
        },
        {
            "endOffset": 21740,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0050",
            "sentence": "The incidence is difficult to ascertain, as data are derived from case reports, but is reported to be 1\u20132 in 10,000.",
            "startOffset": 21624,
            "title": "Intra-abdominal pregnancy"
        },
        {
            "endOffset": 44214,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "Level 1: Criteria as specified in the Antenatal Bleeding case definitions.",
            "startOffset": 44140,
            "title": "Data analysis"
        },
        {
            "endOffset": 44936,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "Not a case of antenatal bleeding.13",
            "startOffset": 44664,
            "title": "Data analysis"
        },
        {
            "endOffset": 27668,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                }
            ],
            "secId": "s0100",
            "sentence": "As previously discussed, the focus of this Working Group is to define pathologic primary causes of antenatal bleeding.",
            "startOffset": 27550,
            "title": "Differentiation from other associated disorders"
        },
        {
            "endOffset": 29760,
            "parents": [
                {
                    "id": "s0115",
                    "title": "Case definition of antenatal bleeding3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0120",
            "sentence": "In the case of ultrasound-based diagnosis, transvaginal ultrasound is more specific than transabdominal ultrasound, and transvaginal ultrasound is recommended where available.",
            "startOffset": 29585,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 26699,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                }
            ],
            "secId": "s0090",
            "sentence": "While the quality of imaging may be superior with gadolinium-enhanced imaging, its use is not currently recommended in pregnancy due to theoretical harms.",
            "startOffset": 26545,
            "title": "Safety of imaging in pregnancy"
        },
        {
            "endOffset": 47226,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "Increments specified above should be used.",
            "startOffset": 47184,
            "title": "Data analysis"
        },
        {
            "endOffset": 20478,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0045",
            "sentence": "A cesarean scar pregnancy is an ectopic pregnancy implanted in a previous cesarean (hysterotomy) scar, surrounded by myometrium and connective tissue.",
            "startOffset": 20328,
            "title": "Cesarean scar pregnancy"
        },
        {
            "endOffset": 27298,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                }
            ],
            "secId": "s0095",
            "sentence": "In order to appropriately assess this question, pregnant women who are and are not exposed to immunizations would need to be prospectively studied to identify any association with antenatal bleeding.",
            "startOffset": 27099,
            "title": "Timing of adverse event with relation to timing of immunization"
        },
        {
            "endOffset": 37597,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                },
                {
                    "id": "s0175",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0185",
            "sentence": "Past medical history, including hospitalizations, underlying diseases/disorders, pre-immunization signs and symptoms including identification of indicators for, or the absence of, a history of allergy to vaccines, vaccine components or medications; food allergy; allergic rhinitis; eczema; asthma.",
            "startOffset": 37300,
            "title": "Clinical and immunization history"
        },
        {
            "endOffset": 14164,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This document will focus solely on the pregnancy-attributable etiologies of antenatal bleeding.",
            "startOffset": 14069,
            "title": "Need for developing case definitions, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 17515,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0030",
            "sentence": "Morbidly adherent placentation occurs when the placenta implants abnormally into the uterine myometrium, rather than the normal implantation of the placenta into the uterine decidua basalis [1,5,7].",
            "startOffset": 17317,
            "title": "Morbidly adherent placentation"
        },
        {
            "endOffset": 50546,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0210",
            "sentence": "Comparison group(s), if used for analysis.",
            "startOffset": 50504,
            "title": "Data presentation"
        },
        {
            "endOffset": 25156,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                },
                {
                    "id": "s0070",
                    "title": "Rationale for individual criteria or decision made related to the case definitions"
                }
            ],
            "secId": "s0075",
            "sentence": "The other etiologies of antenatal bleeding included within this document do not lend themselves to a histologic diagnosis.",
            "startOffset": 25034,
            "title": "Pathology findings"
        },
        {
            "endOffset": 35910,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0165",
            "sentence": "These data elements include an identifiable reporter and patient, one or more prior immunizations, and a detailed description of the adverse event of antenatal bleeding.",
            "startOffset": 35741,
            "title": "Data collection"
        },
        {
            "endOffset": 50114,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0210",
            "sentence": "The method, frequency and duration of monitoring for antenatal bleeding.",
            "startOffset": 50042,
            "title": "Data presentation"
        },
        {
            "endOffset": 16579,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0025",
            "sentence": "The etiology of placenta previa is unknown.",
            "startOffset": 16536,
            "title": "Placenta previa"
        },
        {
            "endOffset": 26277,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                }
            ],
            "secId": "s0090",
            "sentence": "Applying the ALARA (As Low As Reasonably Achievable) principle is recommended during diagnostic imaging procedures [44,45].",
            "startOffset": 26154,
            "title": "Safety of imaging in pregnancy"
        },
        {
            "endOffset": 40422,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                }
            ],
            "secId": "s0195",
            "sentence": "Results of laboratory examinations, surgical and/or pathological findings and diagnoses if present.",
            "startOffset": 40323,
            "title": "The adverse event"
        },
        {
            "endOffset": 44661,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "Reported antenatal bleeding with insufficient evidence to meet the case definition.12",
            "startOffset": 44363,
            "title": "Data analysis"
        },
        {
            "endOffset": 41205,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                }
            ],
            "secId": "s0195",
            "sentence": "Exposures other than the immunization 24 h before and after immunization (e.g. food, environmental) considered potentially relevant to the reported event.",
            "startOffset": 41051,
            "title": "The adverse event"
        },
        {
            "endOffset": 47342,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "When only a small number of cases is presented, the respective values or time course can be presented individually.",
            "startOffset": 47227,
            "title": "Data analysis"
        },
        {
            "endOffset": 11261,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In the vast majority of cases, antenatal bleeding is vaginal and obvious; however, rarely, it may be contained within the uterine cavity, the intraperitoneal space, or the retroperitoneal space.",
            "startOffset": 11067,
            "title": "Need for developing case definitions, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 24348,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                }
            ],
            "secId": "s0065",
            "sentence": "Detailed information about the severity of the event should always be recorded, as specified by the data collection guidelines [43].",
            "startOffset": 24216,
            "title": "Formulating case definitions that reflect diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 23559,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                }
            ],
            "secId": "s0065",
            "sentence": "The case definition has been formulated such that the Level 1 definition is highly specific for the condition.",
            "startOffset": 23449,
            "title": "Formulating case definitions that reflect diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 16187,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "For most conditions, incidence data are derived from settings in which the condition has been most systematically studied, often North America and Western Europe.",
            "startOffset": 16025,
            "title": "Description of sources of antenatal bleeding"
        },
        {
            "endOffset": 35010,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0165",
            "sentence": "These guidelines represent a desirable standard for the collection of available data following immunization to allow for comparability of data, and are recommended as an addition to data collected for the specific study question and setting.",
            "startOffset": 34769,
            "title": "Data collection"
        },
        {
            "endOffset": 42989,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "Reported events should be classified in one of the following five categories including the two levels of diagnostic certainty.",
            "startOffset": 42863,
            "title": "Data analysis"
        },
        {
            "endOffset": 51276,
            "parents": [],
            "secId": "s0215",
            "sentence": "The findings, opinions and assertions contained in this consensus document are those of the individual scientific professional members of the working group.",
            "startOffset": 51120,
            "title": "Disclaimer"
        },
        {
            "endOffset": 29413,
            "parents": [
                {
                    "id": "s0115",
                    "title": "Case definition of antenatal bleeding3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0120",
            "sentence": "The patient is determined to be in the second or third trimester of pregnancy (refer to Brighton Working Group document to establish dating in pregnancy [46]).",
            "startOffset": 29254,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 46723,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "Whatever start and ending are used, they should be used consistently within and across study groups.",
            "startOffset": 46623,
            "title": "Data analysis"
        },
        {
            "endOffset": 16392,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0025",
            "sentence": "Placenta previa occurs when the placenta partially or completely overlies the internal cervical os.",
            "startOffset": 16293,
            "title": "Placenta previa"
        },
        {
            "endOffset": 28956,
            "parents": [
                {
                    "id": "s0115",
                    "title": "Case definition of antenatal bleeding3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0120",
            "sentence": "Antenatal bleeding is a clinical syndrome characterized by bleeding in the second or third trimester of pregnancy.",
            "startOffset": 28842,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 25838,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                },
                {
                    "id": "s0070",
                    "title": "Rationale for individual criteria or decision made related to the case definitions"
                }
            ],
            "secId": "s0085",
            "sentence": "See below regarding safety data.",
            "startOffset": 25806,
            "title": "Radiology findings"
        },
        {
            "endOffset": 47027,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "Analysis may also include other characteristics like qualitative patterns of criteria defining the event.",
            "startOffset": 46922,
            "title": "Data analysis"
        },
        {
            "endOffset": 15000,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The composition of the working and reference group as well as results of the web-based survey completed by the reference group with subsequent discussions in the working group can be viewed at: http://www.brightoncollaboration.org/internet/en/index/working_groups.html.",
            "startOffset": 14731,
            "title": "Methods for the development of the case definition, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 24711,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                },
                {
                    "id": "s0070",
                    "title": "Rationale for individual criteria or decision made related to the case definitions"
                }
            ],
            "secId": "s0075",
            "sentence": "This is the case for morbidly adherent placentation, where the surgical specimen is often the hysterectomy specimen with placenta in-situ.",
            "startOffset": 24573,
            "title": "Pathology findings"
        },
        {
            "endOffset": 11879,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "to define sources of pathologic antenatal bleeding in the second or third trimester of pregnancy that are directly attributable to pregnancy and are either common and/or catastrophic;",
            "startOffset": 11696,
            "title": "Need for developing case definitions, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 13353,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Cesarean scar pregnancy and intra-abdominal pregnancy are rarely listed as causes of antenatal bleeding in the second and third trimester.",
            "startOffset": 13215,
            "title": "Need for developing case definitions, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 24572,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                },
                {
                    "id": "s0070",
                    "title": "Rationale for individual criteria or decision made related to the case definitions"
                }
            ],
            "secId": "s0075",
            "sentence": "In certain cases, pathologic findings serve as the gold standard to confirm the presence of a pathologic entity.",
            "startOffset": 24460,
            "title": "Pathology findings"
        },
        {
            "endOffset": 19516,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0035",
            "sentence": "Pregnancies diagnosed with abruption end 3\u20134 weeks earlier than other pregnancies, with well over half delivering preterm.",
            "startOffset": 19394,
            "title": "Placental abruption"
        },
        {
            "endOffset": 26153,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                }
            ],
            "secId": "s0090",
            "sentence": "Ultrasound is considered safe in pregnancy, and there have been no reports of adverse fetal or neonatal outcomes from prenatal ultrasound imaging.",
            "startOffset": 26007,
            "title": "Safety of imaging in pregnancy"
        },
        {
            "endOffset": 23765,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                }
            ],
            "secId": "s0065",
            "sentence": "As maximum specificity normally implies a loss of sensitivity, an additional diagnostic level has been included in the definition to increase sensitivity while retaining an acceptable level of specificity.",
            "startOffset": 23560,
            "title": "Formulating case definitions that reflect diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 46921,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "If more than one measurement of a particular criterion is taken and recorded, the value corresponding to the greatest magnitude of the adverse experience could be used as the basis for analysis.",
            "startOffset": 46727,
            "title": "Data analysis"
        },
        {
            "endOffset": 49842,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0210",
            "sentence": "However, the mean and standard deviation should also be provided.",
            "startOffset": 49777,
            "title": "Data presentation"
        },
        {
            "endOffset": 36532,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                }
            ],
            "secId": "s0170",
            "sentence": "Name and contact information of person reporting4 and/or diagnosing the antenatal bleeding as specified by country-specific data protection law.",
            "startOffset": 36250,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 35322,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0165",
            "sentence": "Investigators developing a data collection tool based on these data collection guidelines also need to refer to the criteria in the case definition, which are not repeated in these guidelines.",
            "startOffset": 35130,
            "title": "Data collection"
        },
        {
            "endOffset": 26771,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                }
            ],
            "secId": "s0090",
            "sentence": "Nonetheless, clear harm from gadolinium has not been demonstrated [45].",
            "startOffset": 26700,
            "title": "Safety of imaging in pregnancy"
        },
        {
            "endOffset": 27822,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                }
            ],
            "secId": "s0100",
            "sentence": "Labor, whether at term or preterm, may present with vaginal bleeding, yet in this instance, the pathway of preterm labor is the primary pathologic event.",
            "startOffset": 27669,
            "title": "Differentiation from other associated disorders"
        },
        {
            "endOffset": 21341,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0050",
            "sentence": "Intra-abdominal pregnancy is a rare form of an ectopic pregnancy, in which a pregnancy implants into the peritoneal cavity or abdominal organs.",
            "startOffset": 21198,
            "title": "Intra-abdominal pregnancy"
        },
        {
            "endOffset": 50456,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0210",
            "sentence": "The characteristics of the surveillance system (e.g. population served, mode of report solicitation).",
            "startOffset": 50355,
            "title": "Data presentation"
        },
        {
            "endOffset": 37071,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                },
                {
                    "id": "s0175",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0180",
            "sentence": "Case/study participant identifiers (e.g. first name initial followed by last name initial) or code (or in accordance with country-specific data protection laws).",
            "startOffset": 36910,
            "title": "Demographics"
        },
        {
            "endOffset": 40006,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                }
            ],
            "secId": "s0195",
            "sentence": "Date/time of onset,5 first observation6 and diagnosis,7 end of episode8 and final outcome.9",
            "startOffset": 39171,
            "title": "The adverse event"
        },
        {
            "endOffset": 18995,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0035",
            "sentence": "In very rare circumstances abruption can follow second trimester diagnostic and therapeutic intrauterine procedures (amniocentesis, CVS, fetal surgery).",
            "startOffset": 18843,
            "title": "Placental abruption"
        },
        {
            "endOffset": 37102,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                },
                {
                    "id": "s0175",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0180",
            "sentence": "Date of birth, age, and sex.",
            "startOffset": 37074,
            "title": "Demographics"
        },
        {
            "endOffset": 13942,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Non-obstetric genital tract bleeding may also occur during pregnancy, including neoplastic, infectious, traumatic, or iatrogenic causes.",
            "startOffset": 13806,
            "title": "Need for developing case definitions, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 15660,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "This review resulted in a detailed summary of 33 articles used to establish case definitions for antenatal bleeding.",
            "startOffset": 15544,
            "title": "Methods for the development of the case definition, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 21525,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0050",
            "sentence": "Most commonly, this occurs due to tubal ectopic pregnancy with tubal extrusion or rupture and secondary implantation; primary implantation into the peritoneal cavity is also possible.",
            "startOffset": 21342,
            "title": "Intra-abdominal pregnancy"
        },
        {
            "endOffset": 41047,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                }
            ],
            "secId": "s0195",
            "sentence": "Objective clinical evidence supporting classification of the event as \u201cserious\u201d.10",
            "startOffset": 40554,
            "title": "The adverse event"
        },
        {
            "endOffset": 27498,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                }
            ],
            "secId": "s0095",
            "sentence": "However, withholding immunizations in pregnancy would not be ethical, and thus we are left with case reports and other epidemiologic studies of association that may lead to inappropriate conclusions.",
            "startOffset": 27299,
            "title": "Timing of adverse event with relation to timing of immunization"
        },
        {
            "endOffset": 40220,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                }
            ],
            "secId": "s0195",
            "sentence": "Values and units of routinely measured parameters (e.g. temperature, blood pressure) \u2013 in particular those indicating the severity of the event;",
            "startOffset": 40076,
            "title": "The adverse event"
        },
        {
            "endOffset": 22074,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0055",
            "sentence": "Uterine rupture may occur either in an unscarred uterus or at the site of a prior hysterotomy scar.",
            "startOffset": 21975,
            "title": "Uterine rupture"
        },
        {
            "endOffset": 38792,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                }
            ],
            "secId": "s0190",
            "sentence": "Needle length and gauge.",
            "startOffset": 38768,
            "title": "Details of the immunization"
        },
        {
            "endOffset": 35129,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0165",
            "sentence": "They are not intended to guide the primary reporting of antenatal bleeding for a surveillance system or study monitor.",
            "startOffset": 35011,
            "title": "Data collection"
        },
        {
            "endOffset": 21974,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0055",
            "sentence": "Uterine rupture is the complete nonsurgical disruption of all layers of the uterus.",
            "startOffset": 21891,
            "title": "Uterine rupture"
        },
        {
            "endOffset": 36627,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                }
            ],
            "secId": "s0170",
            "sentence": "Name and contact information of the investigator responsible for the subject, as applicable.",
            "startOffset": 36535,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 36907,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                },
                {
                    "id": "s0175",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0180",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 36801,
            "title": "Demographics"
        },
        {
            "endOffset": 36761,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                }
            ],
            "secId": "s0170",
            "sentence": "Relation to the patient (e.g., immunizer or health care provider [clinician, nurse], family member [indicate relationship], other).",
            "startOffset": 36630,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 19963,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0040",
            "sentence": "Type I vasa previa occurs with a velamentous umbilical cord insertion into the membranes, consequently allowing for fetal vessels to run free within the membranes between the umbilical cord and placenta.",
            "startOffset": 19760,
            "title": "Vasa previa"
        },
        {
            "endOffset": 40322,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                }
            ],
            "secId": "s0195",
            "sentence": "Method of measurement (e.g. type of thermometer, oral or other route, duration of measurement, etc.);",
            "startOffset": 40221,
            "title": "The adverse event"
        },
        {
            "endOffset": 18691,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0035",
            "sentence": "Abruptions may either be revealed, with vaginal bleeding as an early symptom, or concealed, with blood remaining trapped within the uterus.",
            "startOffset": 18552,
            "title": "Placental abruption"
        },
        {
            "endOffset": 37841,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                },
                {
                    "id": "s0175",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0185",
            "sentence": "Any medication history (other than treatment for the event described) prior to, during, and after immunization including prescription and non-prescription medication as well as medication or treatment with long half-life or long-term effect.",
            "startOffset": 37600,
            "title": "Clinical and immunization history"
        },
        {
            "endOffset": 49032,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0210",
            "sentence": "Terms to describe antenatal bleeding such as \u201clow-grade\u201d, \u201cmild\u201d, \u201cmoderate\u201d, \u201chigh\u201d, \u201csevere\u201d or \u201csignificant\u201d are highly subjective, prone to wide interpretation, and should be avoided, unless clearly defined.",
            "startOffset": 48821,
            "title": "Data presentation"
        },
        {
            "endOffset": 45723,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "These intervals were arbitrarily chosen, as there is no biologic plausibility between vaccination and antenatal bleeding, as we have previously explained.",
            "startOffset": 45569,
            "title": "Data analysis"
        },
        {
            "endOffset": 46303,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "In addition, we recommend recording both the gestational age at the time of immunization, and the gestational age at the time of the bleeding event.",
            "startOffset": 46155,
            "title": "Data analysis"
        },
        {
            "endOffset": 50835,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0210",
            "sentence": "Whether the date of onset4 and/or the date of first observation5 and/or the date of diagnosis6 was used for analysis.",
            "startOffset": 50718,
            "title": "Data presentation"
        },
        {
            "endOffset": 50290,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0210",
            "sentence": "The trial profile, indicating participant flow during a study including drop-outs and withdrawals to indicate the size and nature of the respective groups under investigation.",
            "startOffset": 50115,
            "title": "Data presentation"
        },
        {
            "endOffset": 25509,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                },
                {
                    "id": "s0070",
                    "title": "Rationale for individual criteria or decision made related to the case definitions"
                }
            ],
            "secId": "s0080",
            "sentence": "Anemia and coagulopathy associated with significant antenatal bleeding are to be diagnosed and managed using usual clinical algorithms.",
            "startOffset": 25374,
            "title": "Laboratory findings"
        },
        {
            "endOffset": 47690,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "Data on antenatal bleeding obtained from subjects receiving a vaccine should be compared with those obtained from an appropriately selected and documented control group(s) to assess background rates of hypersensitivity in non-exposed populations, and should be analyzed by study arm and dose where possible, e.g. in prospective clinical trials.",
            "startOffset": 47346,
            "title": "Data analysis"
        },
        {
            "endOffset": 42859,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "The following guidelines represent a desirable standard for analysis of data on antenatal bleeding to allow for comparability of data, and are recommended as an addition to data analyzed for the specific study question and setting.",
            "startOffset": 42628,
            "title": "Data analysis"
        },
        {
            "endOffset": 20300,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0040",
            "sentence": "Risk factors include resolved low-lying placenta, placenta previa, and multiple gestation [5,30].",
            "startOffset": 20203,
            "title": "Vasa previa"
        },
        {
            "endOffset": 19759,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0040",
            "sentence": "Vasa previa occurs when fetal blood vessels course within the amniotic membranes across the internal cervical os or within 2 cm of the os.",
            "startOffset": 19621,
            "title": "Vasa previa"
        },
        {
            "endOffset": 28612,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0110",
            "sentence": "Similar to all Brighton Collaboration case definitions and guidelines, review of the definition with its guidelines is planned on a regular basis (i.e. every three to five years) or more often if needed.",
            "startOffset": 28409,
            "title": "Periodic review"
        },
        {
            "endOffset": 39167,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                }
            ],
            "secId": "s0195",
            "sentence": "Clinical description of signs and symptoms of antenatal bleeding, and if there was medical confirmation of the event (i.e. patient seen by physician).",
            "startOffset": 39017,
            "title": "The adverse event"
        },
        {
            "endOffset": 18308,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0035",
            "sentence": "Placental abruption occurs when the placenta detaches prematurely from its implantation site.",
            "startOffset": 18215,
            "title": "Placental abruption"
        },
        {
            "endOffset": 44326,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "Event does not meet case definition",
            "startOffset": 44291,
            "title": "Data analysis"
        },
        {
            "endOffset": 40051,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                }
            ],
            "secId": "s0195",
            "sentence": "Concurrent signs, symptoms, and diseases.",
            "startOffset": 40010,
            "title": "The adverse event"
        },
        {
            "endOffset": 12709,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "To date, there is one case report of antenatal bleeding occurring in a pregnancy where a tetanus, diphtheria, and acellular pertussis vaccination was also administered [2].",
            "startOffset": 12537,
            "title": "Need for developing case definitions, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 26544,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                }
            ],
            "secId": "s0090",
            "sentence": "There has never been any documented fetal or neonatal harm and the procedure is considered safe in pregnancy.",
            "startOffset": 26435,
            "title": "Safety of imaging in pregnancy"
        },
        {
            "endOffset": 37907,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                },
                {
                    "id": "s0175",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0185",
            "sentence": "(e.g. immunoglobulins, blood transfusion and immunosuppressants).",
            "startOffset": 37842,
            "title": "Clinical and immunization history"
        },
        {
            "endOffset": 48817,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0210",
            "sentence": "Data on possible antenatal bleeding events should be presented in accordance with data collection guidelines 1\u201324 (verify numbers) and data analysis guidelines 31\u201336 (verify numbers).",
            "startOffset": 48634,
            "title": "Data presentation"
        },
        {
            "endOffset": 20646,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0045",
            "sentence": "This occurs due to a small defect in the cesarean scar, as a result of poor healing and poor vascularization of the lower uterine segment with resultant fibrosis [31].",
            "startOffset": 20479,
            "title": "Cesarean scar pregnancy"
        },
        {
            "endOffset": 20931,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0045",
            "sentence": "Cesarean scar pregnancies occur in about 1 in 2000 pregnancies and account for 6% of ectopic pregnancies among women with a prior cesarean delivery [31].",
            "startOffset": 20778,
            "title": "Cesarean scar pregnancy"
        },
        {
            "endOffset": 34545,
            "parents": [],
            "secId": "s0160",
            "sentence": "The availability of information may vary depending upon resources, geographical region, and whether the source of information is a prospective clinical trial, post-marketing surveillance or epidemiological study, or an individual report of antenatal bleeding.",
            "startOffset": 34286,
            "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
        },
        {
            "endOffset": 23868,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                }
            ],
            "secId": "s0065",
            "sentence": "In this way, it is hoped that all possible cases of antenatal bleeding can be systematically captured.",
            "startOffset": 23766,
            "title": "Formulating case definitions that reflect diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 40517,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                }
            ],
            "secId": "s0195",
            "sentence": "Treatment given for antenatal bleeding, including blood transfusion and timing of delivery.",
            "startOffset": 40426,
            "title": "The adverse event"
        },
        {
            "endOffset": 40550,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                }
            ],
            "secId": "s0195",
            "sentence": "Outcome8 at last observation.",
            "startOffset": 40521,
            "title": "The adverse event"
        },
        {
            "endOffset": 50717,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0210",
            "sentence": "Whether the day of immunization was considered \u201cday one\u201d or \u201cday zero\u201d in the analysis.",
            "startOffset": 50630,
            "title": "Data presentation"
        },
        {
            "endOffset": 51110,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0210",
            "sentence": "Use of this case definition for antenatal bleeding, in the abstract or methods section of a publication.14",
            "startOffset": 50836,
            "title": "Data presentation"
        },
        {
            "endOffset": 14068,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Urinary tract infections or hemorrhoids may also be misidentified as antenatal bleeding until additional workup is performed.",
            "startOffset": 13943,
            "title": "Need for developing case definitions, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 21871,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0050",
            "sentence": "Risk factors are artificial insemination, in vitro fertilization, uterine surgeries, and prior tubal or cornual pregnancy [33,34].",
            "startOffset": 21741,
            "title": "Intra-abdominal pregnancy"
        },
        {
            "endOffset": 12805,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "However, the definition used to identify the antenatal bleeding event is not clearly presented.",
            "startOffset": 12710,
            "title": "Need for developing case definitions, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 13805,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This is not addressed in our document.",
            "startOffset": 13767,
            "title": "Need for developing case definitions, and guidelines for data collection, analysis, and presentation for antenatal bleeding as an adverse event"
        },
        {
            "endOffset": 17752,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Description of sources of antenatal bleeding"
                }
            ],
            "secId": "s0030",
            "sentence": "The incidence of morbidly adherent placentation is 1 in 300 to 1 in 500 pregnancies [5].",
            "startOffset": 17664,
            "title": "Morbidly adherent placentation"
        },
        {
            "endOffset": 37297,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                },
                {
                    "id": "s0175",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0185",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 37191,
            "title": "Clinical and immunization history"
        },
        {
            "endOffset": 26434,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0060",
                    "title": "Rationale for selected decisions about case definitions for antenatal bleeding as an adverse event"
                }
            ],
            "secId": "s0090",
            "sentence": "Magnetic resonance imaging (MRI) technology has also been used in pregnancy for several indications after inconclusive or nondiagnostic prenatal ultrasound.",
            "startOffset": 26278,
            "title": "Safety of imaging in pregnancy"
        },
        {
            "endOffset": 38764,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                },
                {
                    "id": "s0165",
                    "title": "Data collection"
                }
            ],
            "secId": "s0190",
            "sentence": "Route and method of administration (e.g. intramuscular, intradermal, subcutaneous, and needle-free (including type and size), other injection devices).",
            "startOffset": 38613,
            "title": "Details of the immunization"
        },
        {
            "endOffset": 45421,
            "parents": [
                {
                    "id": "s0160",
                    "title": "Guidelines for data collection, analysis and presentation of antenatal bleeding"
                }
            ],
            "secId": "s0205",
            "sentence": "Subjects with Antenatal Bleeding (specify which etiology) by Interval to Presentation",
            "startOffset": 45336,
            "title": "Data analysis"
        }
    ],
    "docId": "S0264410X17301615",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "mprabhu@partners.org",
                "first": "Malavika",
                "initial": "M.",
                "last": "Prabhu"
            },
            {
                "email": null,
                "first": "Linda O.",
                "initial": "L.O.",
                "last": "Eckert"
            },
            {
                "email": null,
                "first": "Michael",
                "initial": "M.",
                "last": "Belfort"
            },
            {
                "email": null,
                "first": "Isaac",
                "initial": "I.",
                "last": "Babarinsa"
            },
            {
                "email": null,
                "first": "Cande V.",
                "initial": "C.V.",
                "last": "Ananth"
            },
            {
                "email": null,
                "first": "Robert M.",
                "initial": "R.M.",
                "last": "Silver"
            },
            {
                "email": null,
                "first": "Elizabeth",
                "initial": "E.",
                "last": "Stringer"
            },
            {
                "email": null,
                "first": "Lee",
                "initial": "L.",
                "last": "Meller"
            },
            {
                "email": null,
                "first": "Jay",
                "initial": "J.",
                "last": "King"
            },
            {
                "email": null,
                "first": "Richard",
                "initial": "R.",
                "last": "Hayman"
            },
            {
                "email": null,
                "first": "Sonali",
                "initial": "S.",
                "last": "Kochhar"
            },
            {
                "email": null,
                "first": "Laura",
                "initial": "L.",
                "last": "Riley"
            },
            {
                "email": null,
                "first": null,
                "initial": null,
                "last": null
            }
        ],
        "doi": "10.1016/j.vaccine.2017.01.081",
        "firstpage": "6529",
        "issn": "0264410X",
        "keywords": [
            "Adverse event",
            "Antenatal bleeding",
            "Case definition",
            "Guidelines",
            "Immunization"
        ],
        "lastpage": "6537",
        "openaccess": "Full",
        "pub_year": 2017,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Antenatal bleeding: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data"
    }
}